BasuNephro

Cosmic kidney disease: an integrated pan-omic, physiological and morphological study into spaceflight-induced renal dysfunction - Nature Communications Siew et al. using multi-omic, physiological & imaging approaches have demonstrated that spaceflight causes kidney remodelling, suggesting a contribution to kidney stone formation, & that space...

#Cosmic #kidney disease: the new K(I)D on the space block (pun intended) : you can leave the earth but can't leave the #nephrologists behind 😂 www.nature.com/articles/s41...

10.05.2025 04:00 — 👍 5    🔁 2    💬 0    📌 0

08.04.2025 23:33 — 👍 2    🔁 1    💬 0    📌 0

#nephmadness Rank 5 needs a celebration!!

www.tourneytopia.com/AJKD/NephMad...

Thanks to @nephrologista.bsky.social for rekindling our interest in Nephmadness this year!!

08.04.2025 23:33 — 👍 3    🔁 1    💬 1    📌 0

NephMadness 2025: drbasug's Entry #842842

Got to show off when you get this close #nephmadness 2025.
www.tourneytopia.com/AJKD/NephMad...

Despite the #blueribbon fails!!

07.04.2025 11:15 — 👍 2    🔁 1    💬 0    📌 0

Had a wonderful time at my Alma Mater CMC Vellore for the 3rd paediatric transplant conference !! It's amazing to see the growth in this area and thoroughly enjoyed the rich interactions with the pediatric and adult Nephrology teams !!

23.03.2025 04:01 — 👍 3    🔁 0    💬 0    📌 0

Obinutuzumab in Rituximab-resistant and recurrent membranous nephropathy: a case-series - Journal of Nephrology Background Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults, with high risk of progression to end-stage kidney disease when untreated. Rituximab is commonly used in its tr...

Obinutuzumab for Ritux resistant Membranous Nephropathy - our experience a case series! link.springer.com/article/10.1... @hollyhutton.bsky.social

07.03.2025 05:31 — 👍 2    🔁 1    💬 0    📌 0

🔬 Muddy brown casts, a highly specific #urinarysediment finding of acute tubular injury (bright field, x400).

#nephsky #skyneph

20.11.2024 22:33 — 👍 11    🔁 3    💬 1    📌 0

Action Intent Links | Bluesky Authors, websites, and apps can use action intent links to implement "Share on Bluesky" buttons, or similar in-app actions. Logged-in users will be directed to the corresponding action view in the Blu...

We strongly suggest that academic publishers and other platforms that host research rapidly implement a Share to Bluesky button for their articles. Here's how:

docs.bsky.app/docs/advance...

#AcademicSky #HigherEd #Altmetrics

18.11.2024 14:48 — 👍 11451    🔁 4632    💬 173    📌 248

17.11.2024 21:52 — 👍 2    🔁 0    💬 0    📌 0

Reminder that EM is still useful even when no gloms available. Example case of light chain deposition disease. IF highly suspicious with kappa restriction along tubular basement membranes; EM was helpful to confirm the diagnosis: powdery deposits on TBMs. #renalpath #nephrology #pathsky

17.11.2024 18:48 — 👍 30    🔁 8    💬 2    📌 0

Verification of kidney biopsy adequacy by visualization of glomeruli (bright solid red circles) in the biopsy core. #KidneyBiopsyAcademy

15.11.2024 16:03 — 👍 56    🔁 18    💬 1    📌 2

Nephrology - is not for normal doctors but for exceptionally skilled physicians 😎
#nephsky

from
www.thelancet.com/journals/lan....

14.11.2024 13:17 — 👍 35    🔁 13    💬 4    📌 1

An algorithmic approach to genetic 🧬 testing in patients with FSGS 🔬 and implications in adult patients ca. 2024
#Nephpearls

👉 pubmed.ncbi.nlm.nih.gov/38765809/

12.11.2024 18:47 — 👍 17    🔁 4    💬 0    📌 0

Nice to see familiar faces of the Nephrology global community here!! Thanks for the starter pack !!

12.11.2024 19:10 — 👍 3    🔁 0    💬 0    📌 0

Welcome to all those newly joined!

The second nephrology starter pack is growing

Pack 2: go.bsky.app/N27Kzri

OG pack: bsky.app/start/did:pl...

Go to clearly.app and type your handle to figure out which pack(s) you are in!

If you are a neph interested person and in neither, drop a line here

12.11.2024 11:12 — 👍 25    🔁 6    💬 2    📌 0

Can we get some of the other discipline starter packs as well? I think that was also another benefit is seeing what was happening in other specialties.

12.11.2024 13:55 — 👍 12    🔁 1    💬 2    📌 0